Search PDMR transactions

Notifier
Name of person with notification obligation
Marcus Bosson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Marcus Bosson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
QuiaPEG Pharmaceuticals Holding AB
Issuer’s LEI code
967600JUP7EI6X9D2Z44
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 73,545 Quantity 1.535 SEK 30/12/2020 NASDAQ STOCKHOLM AB
Share QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 26,455 Quantity 1.66 SEK 04/01/2021 NASDAQ STOCKHOLM AB
Share QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 20,000 Quantity 1.68 SEK 07/01/2021 NASDAQ STOCKHOLM AB
Share QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 30,000 Quantity 1.69 SEK 07/01/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 30/12/2020 NASDAQ STOCKHOLM AB 73,545 (Quantity) 1.535 SEK
QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 04/01/2021 NASDAQ STOCKHOLM AB 26,455 (Quantity) 1.66 SEK
QuiaPEG Pharmaceuticals Holding AB SE0001384850 Acquisition 07/01/2021 NASDAQ STOCKHOLM AB 50,000 (Quantity) 1.686 SEK
Total: 150,000
<< Back